These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Plasma fibrinolytic system and blood pressure in patients with hypertensive cardiovascular disease treated with reserpine and phenformin. Worowski K; Prokopowicz J; Gabryelewicz A Haematologia (Budap); 1970; 4(3):399-403. PubMed ID: 4256949 [No Abstract] [Full Text] [Related]
4. Abnormalities in clotting and thrombolysis as a risk factor for stroke. Pilgeram LO Thromb Diath Haemorrh; 1974 May; 31(2):245-64. PubMed ID: 4850366 [No Abstract] [Full Text] [Related]
5. Resting levels of blood fibrinolysis in hyperlipoproteinemia. Brakman P; Astrup T; Levy RI; Fredrickson DS J Appl Physiol; 1974 Apr; 36(4):430-3. PubMed ID: 4274385 [No Abstract] [Full Text] [Related]
6. Abnormalities of fibrinolysis in essential hypertension. Ettenger MM; MacCarthy EP; Glas-Greenwalt P; Clyne DH; Pollak VE J Hypertens Suppl; 1984 Dec; 2(3):S175-8. PubMed ID: 6242555 [TBL] [Abstract][Full Text] [Related]
7. [Study on the relationship between changes of blood lipids and the fibrinolytic picture in ambulatory patients with arteriosclerosis]. Rugginenti A Minerva Med; 1974 May; 65(34):1873-7. PubMed ID: 4842771 [No Abstract] [Full Text] [Related]
8. [Fibrinolytic system of blood in patients with hypertensive disease]. Fatkhullaev IF; Agapova LA Ter Arkh; 1974; 46(6):24-7. PubMed ID: 4279461 [No Abstract] [Full Text] [Related]
9. [Changes in the fibrinolytic system of the blood in patients with hypertension with coronary arteriosclerosis and circulatory insufficiency]. Aslanian NL; Dolabchian ZL; Shukhian VM; Demirchian AKh; Khachaturova IA Kardiologiia; 1972 Jul; 12(7):106-9. PubMed ID: 4670631 [No Abstract] [Full Text] [Related]
10. [Clinical value of the measure of global fibrinolytic activity]. Guillaume M; Zouaoui Boudjeltia K; Cauchie P; Hénuzet C Rev Med Brux; 2001 Apr; 22(2):A115-7. PubMed ID: 11388033 [No Abstract] [Full Text] [Related]
11. [Changes of haemostatic parameters in patients with acute cardioembolic stroke]. Maksimova MIu; Domashenko MA; Ionova VG; Mikhal'chenko VN; Syskina EN; Okhtova FR Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12 Pt 2):22-7. PubMed ID: 22792744 [TBL] [Abstract][Full Text] [Related]
12. Impaired fibrinolytic response to exercise in patients with type-IV hyperlipoproteinaemia. Epstein SE; Brakman P; Rosing DR; Redwood DR Lancet; 1970 Sep; 2(7674):631-4. PubMed ID: 4195770 [No Abstract] [Full Text] [Related]
13. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. II. Relations of the variables to "risk factors" for myocardial infarction. Korsan-Bengtsen K; Wilhelmsen L; Tibblin G Thromb Diath Haemorrh; 1972 Aug; 28(1):99-108. PubMed ID: 5074994 [No Abstract] [Full Text] [Related]
14. [Plasminogen, antiplasmins and the rate of fibrinolysis in hypertension and atherosclerosis]. Gritsiuk AI Kardiologiia; 1968 May; 8(5):54-8. PubMed ID: 5671692 [No Abstract] [Full Text] [Related]
16. [Fibrinolytic activity in Behçet's disease]. Kogure M; Motoji K Nippon Ganka Gakkai Zasshi; 1972 Mar; 76(3):114-21. PubMed ID: 4261805 [No Abstract] [Full Text] [Related]
17. [Analytical methods of study of the system of fibrinolysis (plasminogen proactivators-activators, plasminogen-plasmin, antiplasmins, antiactivators) (literature review)]. Guseĭnov ChS; Golovastova GI; Gorelova AM; Cherenkova GM; Mikhailova ND Lab Delo; 1976; (5):276-83. PubMed ID: 62085 [No Abstract] [Full Text] [Related]
18. [Correlative study of fibrinolysis and some indices of blood coagulation and lipid metabolism in arteriosclerotic disease]. Craveri A; Repaci G; Cerrini R; Saracino F G Clin Med; 1969 Aug; 50(8):684-98. PubMed ID: 4243678 [No Abstract] [Full Text] [Related]
19. [Changes in the area of the chemical parameters during streptokinase infusion]. Amery A; Vermylen J; Verstraete M Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):7-19. PubMed ID: 4189377 [No Abstract] [Full Text] [Related]